Table 4.

The haplotype analysis of EGFR polymorphisms in the occurrence of AD.

Haplotype Site1-site2-site3	Case, 2n=278/%	Control, 2n=304/%	OR (95%CI)	P
A-T-T	98/35.25	139/45.72	Ref.	–
A-C-C	42/15.11	31/10.20	1.922 (1.130, 3.269)	0.015
C-T-C	99/35.61	129/42.43	1.089 (0.753, 1.573)	0.651

Site1 – rs730437; site2 – rs3752651; site3 – rs1468727.